Von Willebrand Disease

Co-Pay Relief Program Fund Notices

Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!

Get Notified


Approved and Donation Ready

This fund has been developed in response to patients who have contacted PAF for help with their medication expenses and could not find help. While this fund has been fully designed and we are ready to provide needed support to these patient communities, this fund is not yet able to accept applications for assistance as we are still working to secure charitable donations that will allow us to open it.

If you, or someone you know, would like to contribute to this fund, please visit our Donors page for more information on how to provide critical support for patients in need.

Fund Type

Co-Pay, Co-insurance & Deductible (medications and office visits), Medical Insurance Premiums

Maximum Award Level


Eligibility Requirements
  • Household Income Requirements 400% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
  • Insurance Requirements All Insurance Types
  • Must reside and receive treatment in the United States.

About Von Willebrand Disease

Von Willebrand disease is a common inherited genetic disorder caused by missing or defective von Willebrand factor (VWF), a clotting protein, slowing the blood clotting process after an injury, surgery or dental work.  VFW binds factor VIII and platelets in the blood vessel walls, which help form a platelet plug.  There are three types of Von Willebrand disease: Type 1 is the mildest and most common type, accounting for 85% of cases and Type 3 is the most severe and rarest form of the disease, affecting 3% of people with VWD.  People with type 2 have a qualitative deficiency in the VWF ranging from mild to moderate, these subtypes are: type 2A, type 2B, type 2M and type 2N. Acquired VWD is rare and results after a diagnosis of another medical condition such as autoimmune disease (e.g. lupus), heart disease or some type of cancer. VWD is the most common bleeding disorder in the U.S., found in up to 1% of the U.S. population, affecting men and women equally and is characterized by mucocutaneous bleeding. Von Willebrand disease is known as angiohemophilia, vascular pseudohemophilia, von Willebrand disorder, von Willebrand’s factor deficiency.

Von Willebrand Disease Resources
Medication & Financial Assistance Resources
The Patient Advocate Foundation's (PAF) Co-Pay Relief (CPR) Program does not review the information contained on the website links provided for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions as outlined on the accessed websites. PAF Co-Pay Relief Program makes no representation as to the accuracy or any other aspect of the information contained on any website accessed from the CPR website, nor does PAF Co-Pay Relief Program necessarily endorse the website information provided. The information presented on the PAF Co-Pay Relief website is provided for general information only and is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you acquire from this or any other website accessed through the PAF Co-Pay Relief program website.